Caitong International Asset Management’s China SXT Pharmaceuticals SXTC Stock Holding History

Caitong International Asset Management's SXTC Position: Q2 2026 in Review

Caitong International Asset Management increased its China SXT Pharmaceuticals (SXTC) stake by 100% in Q2 2026, buying an estimated $2 and bringing the position to 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #2774.

Caitong International Asset Management first reported a position in SXTC in Q1 2026 and has held it in 2 quarters since. 1 fund tracked by Wall St. Rank holds SXTC as of Q2 2026.

• Caitong International Asset Management held 2 shares of China SXT Pharmaceuticals worth $4 as of Q2 2026.
• Caitong International Asset Management bought 1 China SXT Pharmaceuticals share in Q2 2026, an estimated $2.
• China SXT Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2774 holding.
• Caitong International Asset Management first reported a position in China SXT Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
• 1 fund tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.